Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Shares, no par value per share
-
Shares outstanding
-
47,601,550
-
Total 13F shares
-
14,249,424
-
Share change
-
+342,862
-
Total reported value
-
$56,595,712
-
Price per share
-
$4.00
-
Number of holders
-
15
-
Value change
-
+$1,340,512
-
Number of buys
-
3
-
Number of sells
-
7
Institutional Holders of ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) as of Q1 2020
As of 31 Mar 2020 ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) had 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 14,249,424 shares of stock of the company.
Largest 10 holders included Blackstone Group Inc, BVF INC/IL, Soleus Capital Management, L.P., EVENTIDE ASSET MANAGEMENT, LLC, Omega Fund Management, LLC, ORBIMED ADVISORS LLC, RA CAPITAL MANAGEMENT, L.P., JANUS HENDERSON GROUP PLC, COMMONWEALTH EQUITY SERVICES, LLC, and CIBC World Markets Inc..
This table shows 15 institutional shareholders of the security as of 31 Mar 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.